CLINICAL_TRIALS
trial_result
· 2026-01-23
Clinical Trial Update: Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) [Phase 3]
Summary
A Phase 3 trial (LIMIT-JIA) evaluating strategies to prevent progression in oligoarticular juvenile idiopathic arthritis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Duke University | Conditions: Juvenile Idiopathic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2026-01-23